fluconazole has been researched along with Systemic Inflammatory Response Syndrome in 5 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Systemic Inflammatory Response Syndrome: A systemic inflammatory response to a variety of clinical insults, characterized by two or more of the following conditions: (1) fever
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hematologic malignancy and neutropenia were significantly more frequent in children than in neonates and adults." | 1.35 | Not just little adults: candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients. ( Blyth, CC; Chen, SC; Ellis, D; Marriott, D; Meyer, W; Nguyen, Q; Serena, C; Slavin, MA; Sorrell, TC, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liao, X | 1 |
| Qiu, H | 1 |
| Li, R | 1 |
| Guo, F | 1 |
| Liu, W | 1 |
| Kang, M | 1 |
| Kang, Y | 1 |
| Murri, R | 1 |
| Scoppettuolo, G | 1 |
| Ventura, G | 1 |
| Fabbiani, M | 1 |
| Giovannenze, F | 1 |
| Taccari, F | 1 |
| Milozzi, E | 1 |
| Posteraro, B | 1 |
| Sanguinetti, M | 1 |
| Cauda, R | 1 |
| Fantoni, M | 1 |
| Blyth, CC | 1 |
| Chen, SC | 1 |
| Slavin, MA | 1 |
| Serena, C | 1 |
| Nguyen, Q | 1 |
| Marriott, D | 1 |
| Ellis, D | 1 |
| Meyer, W | 1 |
| Sorrell, TC | 1 |
| Mauric, O | 1 |
| Thallinger, C | 1 |
| Kugler, SA | 1 |
| Joukhadar, SM | 1 |
| Kovar, FM | 1 |
| Konz, KH | 1 |
| Graninger, W | 1 |
| Joukhadar, C | 1 |
| Wierzbicka, M | 1 |
1 review available for fluconazole and Systemic Inflammatory Response Syndrome
| Article | Year |
|---|---|
[Progress and new perspective treatments of systemic fungal infections].
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Forecasting; Humans; Itraconazole; Mycoses; Systemic | 1999 |
4 other studies available for fluconazole and Systemic Inflammatory Response Syndrome
| Article | Year |
|---|---|
Risk factors for fluconazole-resistant invasive candidiasis in intensive care unit patients: An analysis from the China Survey of Candidiasis study.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Candidiasis, Invasive; Carrier State; Ch | 2015 |
Initial antifungal strategy does not correlate with mortality in patients with candidemia.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Candida albicans; Candida glabrata; Candidemia; Coho | 2016 |
Not just little adults: candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients.
Topics: Adult; Amphotericin B; Antifungal Agents; Australia; Candida albicans; Candidiasis; Child; Child, Pr | 2009 |
The ability of fluconazole to penetrate into ventilated, healthy and inflamed lung tissue in a model of severe sepsis in rats.
Topics: Animals; Antifungal Agents; Blood Proteins; Disease Models, Animal; Extracellular Space; Fluconazole | 2011 |